VIRTUAL EVENT
The 2nd Gene Therapy for Blood Disorders meeting will focus on the clinical and commercial challenges of developing gene therapies targeting hemophilia, sickle cell disease and beta thalassemia.
The 2nd Gene Therapy for Blood Disorders meeting will focus on the clinical and commercial challenges of developing gene therapies targeting hemophilia, sickle cell disease and beta thalassemia.
By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.